AAP

Promoting Drug Safety During Breastfeeding
Promoting Drug Safety During BreastfeedingPharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
How to build an effective and financially sound vaccine programFor practices that do not routinely offer vaccinations or are struggling to maintain a successful program, we would like to offer a basic outline of the process our practice used.
Telemedicine: Good for the long haul?As the popularity of telemedicine grows, the American Academy of Pediatrics offers guidance on the best ways to use this emerging technology.
AAP shifts focus for managing child obesityThe American Academy of Pediatrics (AAP) has unveiled new recommendations for pediatricians treating children and adolescents who have become obese.
Bronchiolitis guidelines: Diagnosis, management, and preventionBronchiolitis, an acute inflammatory injury of the bronchioles, is the most common cause of lower respiratory tract infection in children aged younger than 12 months.
New AAP guidance for RSV drug spurs manufacturer reactionThe American Academy of Pediatrics (AAP) revision of its recommendations for use of palivizumab (Synagis, MedImmune Specialty Care Division of AstraZeneca) for respiratory syncytial virus (RSV) in infants has fueled a reaction from the drug’s manufacturer.
Guidance on off-label drug use in pediatric population updatedThe American Academy of Pediatrics (AAP) has issued a policy statement updating its recommendations for off-label drug use in the pediatric population.
AAP publishes guidelines for managing pediatric C. difficile infectionsThe American Academy of Pediatrics (AAP) has published a policy statement to provide pediatricians with recommendations for assessing and treating Clostridium difficile infections (CDI) in children.
American Academy of Pediatrics: Retain thimerosal for global vaccine useThe American Academy of Pediatrics has announced its endorsement of the World Health Organization's (WHO) recommendation that thimerosal not be banned from vaccines.
American Academy of Pediatrics- Retain thimerosal for global vaccine useThe American Academy of Pediatrics has announced its endorsement of the World Health Organization's (WHO) recommendation that thimerosal not be banned from vaccines.